Oculis Holding AG (OCS) Interest & Investment Income (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Interest & Investment Income of $468660.7 in Q1 2026, down 78.84% quarter-over-quarter from $2.2 million in Q4 2025, and down 14.53% on a YoY basis from $548339.5 in Q1 2025.

Oculis Holding AG (OCS) Interest & Investment Income (2021 - 2026) Analysis & Trends

Oculis Holding AG's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $468660.7 for Q1 2026.

  • In Q1 2026, Interest & Investment Income fell 14.53% year-over-year to $468660.7; the TTM figure through Mar 2026 stood at $468660.7 (down 14.53% YoY), while the FY2025 annual figure was $2.2 million, down 10.52% from the prior year.
  • Interest & Investment Income was $468660.7 for Q1 2026 at Oculis Holding AG, down from $2.2 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.1 billion in Q3 2024 to a low of $8306.3 in Q2 2022.
  • Historically, Interest & Investment Income has averaged $243.8 million across 5 years, with a median of $770397.7 in 2024.
  • The sharpest annual moves came in 2024 and 2025: Interest & Investment Income soared 236899.5% in 2024, then declined 17.62% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at $130790.8 in 2022, then surged by 1131.73% to $1.6 million in 2023, then jumped by 53.62% to $2.5 million in 2024, then decreased by 10.52% to $2.2 million in 2025, then plunged by 78.84% to $468660.7 in 2026.
  • The last three Interest & Investment Income figures came in at $468660.7 (Q1 2026), $2.2 million (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 597,319.59
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 305,000.00
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 103,341.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 114.80 Mn
9 Abivax 90.15 Bn 90.15 Bn - -14.79 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 468,660.72

Historic Data

Download Data
DateValue
Mar 31, 2026 468,660.72
Dec 31, 2025 2.21 Mn
Sep 30, 2025 1.81 Bn
Jun 30, 2025 1.22 Mn
Mar 31, 2025 548,339.51
Dec 31, 2024 2.47 Mn
Sep 30, 2024 2.07 Bn
Jun 30, 2024 1.37 Mn
Mar 31, 2024 665,641.42
Dec 31, 2023 1.61 Mn
Sep 30, 2023 875,153.93
Jun 30, 2023 281,380.41
Mar 31, 2023 35,678.37
Dec 31, 2022 130,790.76
Sep 30, 2022 72,481.96
Jun 30, 2022 8,306.34
Dec 31, 2021 22,774.54